MaxCyte, Inc. Lease, Cost
MaxCyte, Inc. (MXCT) reported Lease, Cost of $933.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-13
- MaxCyte, Inc. lease, cost for the quarter ending 2026-06-30 was $933.00K, a 10.15% increase year-over-year.
- MaxCyte, Inc. lease, cost for the quarter ending 2026-03-31 was $850.00K, a 6.52% increase year-over-year.
- MaxCyte, Inc. lease, cost for the quarter ending 2025-12-31 was $654.00K, a 25.53% increase year-over-year.
- MaxCyte, Inc. lease, cost for the quarter ending 2025-09-30 was $816.00K, a 9.09% increase year-over-year.
- MaxCyte, Inc. lease, cost for fiscal 2025 was $3.12M, a 12.58% increase from fiscal 2024.
- MaxCyte, Inc. lease, cost for fiscal 2024 was $2.77M, a 4.73% increase from fiscal 2023.
- MaxCyte, Inc. lease, cost for fiscal 2023 was $2.64M, a 20.04% increase from fiscal 2022.
- MaxCyte, Inc. lease, cost for fiscal 2022 was $2.20M, a 96.10% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $933.00K 10-Q · filed 2026-08-13 | $1.78M 10-Q · filed 2026-08-13 | $2.44M derived: sum of 3 quarters · filed 2026-08-13 | $3.25M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $850.00K 10-Q · filed 2026-05-13 | $1.50M derived: sum of 2 quarters · filed 2026-05-13 | $2.32M derived: sum of 3 quarters · filed 2026-05-13 | $3.17M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.47M derived: sum of 2 quarters · filed 2026-03-25 | $2.32M derived: sum of 3 quarters · filed 2026-08-13 | $3.12M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $816.00K 10-Q · filed 2025-11-13 | $1.66M derived: sum of 2 quarters · filed 2026-08-13 | $2.46M 10-Q · filed 2025-11-13 | $2.98M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $847.00K 10-Q · filed 2026-08-13 | $1.65M 10-Q · filed 2026-08-13 | $2.17M derived: sum of 3 quarters · filed 2026-08-13 | $2.91M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $798.00K 10-Q · filed 2026-05-13 | $1.32M derived: sum of 2 quarters · filed 2026-05-13 | $2.07M derived: sum of 3 quarters · filed 2026-05-13 | $2.82M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $521.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.27M derived: sum of 2 quarters · filed 2026-03-25 | $2.02M derived: sum of 3 quarters · filed 2026-03-25 | $2.77M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $748.00K 10-Q · filed 2025-11-13 | $1.50M derived: sum of 2 quarters · filed 2025-11-13 | $2.25M 10-Q · filed 2025-11-13 | $2.94M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $749.00K 10-Q · filed 2025-08-06 | $1.50M 10-Q · filed 2025-08-06 | $2.19M derived: sum of 3 quarters · filed 2025-08-06 | $2.87M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $749.00K 10-Q · filed 2025-05-08 | $1.44M derived: sum of 2 quarters · filed 2025-05-08 | $2.12M derived: sum of 3 quarters · filed 2025-05-08 | $2.73M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $692.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.37M derived: sum of 2 quarters · filed 2025-03-11 | $1.98M derived: sum of 3 quarters · filed 2025-03-11 | $2.64M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $681.00K 10-Q · filed 2024-11-06 | $681.20K 10-Q · filed 2023-11-08 | $1.28M derived: sum of 2 quarters · filed 2024-11-06 | $1.95M 10-Q · filed 2024-11-06 | $1.95M 10-Q · filed 2023-11-08 | $2.49M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $604.00K 10-Q · filed 2024-08-06 | $603.90K 10-Q · filed 2023-08-09 | $1.27M 10-Q · filed 2024-08-06 | $1.26M 10-Q · filed 2023-08-09 | $1.81M derived: sum of 3 quarters · filed 2024-08-06 | $2.36M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $664.00K 10-Q · filed 2024-05-07 | $664.60K 10-Q · filed 2023-05-10 | $1.21M derived: sum of 2 quarters · filed 2024-05-07 | $1.76M derived: sum of 3 quarters · filed 2024-05-07 | $2.36M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $543.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.10M derived: sum of 2 quarters · filed 2024-03-12 | $1.70M derived: sum of 3 quarters · filed 2024-03-12 | $2.20M 10-K · filed 2024-03-12 | $2.20M 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $552.40K 10-Q · filed 2023-11-08 | $1.15M derived: sum of 2 quarters · filed 2023-11-08 | $1.66M 10-Q · filed 2023-11-08 | $1.94M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $601.50K 10-Q · filed 2023-08-09 | $1.11M 10-Q · filed 2023-08-09 | $1.39M derived: sum of 3 quarters · filed 2023-08-09 | $1.66M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $503.80K 10-Q · filed 2023-05-10 | $784.60K derived: sum of 2 quarters · filed 2023-05-10 | $1.06M derived: sum of 3 quarters · filed 2023-05-10 | $1.34M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $280.80K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $551.60K derived: sum of 2 quarters · filed 2023-03-15 | $838.10K derived: sum of 3 quarters · filed 2023-03-15 | $1.12M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $270.80K 10-Q · filed 2022-11-09 | $557.30K derived: sum of 2 quarters · filed 2022-11-09 | $841.60K 10-Q · filed 2022-11-09 | $1.12M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $286.50K 10-Q · filed 2022-08-10 | $570.70K 10-Q · filed 2022-08-10 | $850.40K derived: sum of 3 quarters · filed 2022-08-10 | $1.13M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $284.00K 10-Q · filed 2022-05-09 | $563.90K derived: sum of 2 quarters · filed 2022-05-09 | $843.00K derived: sum of 3 quarters · filed 2022-05-09 | $1.11M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $279.90K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $559.00K derived: sum of 2 quarters · filed 2022-03-22 | $822.80K derived: sum of 3 quarters · filed 2022-03-22 | $1.08M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $279.10K 10-Q · filed 2021-11-10 | $542.90K derived: sum of 2 quarters · filed 2021-11-10 | $800.40K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $263.80K 10-Q · filed 2021-09-13 | $521.30K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | $768.80K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |